Browsing by Author "Chamorro Veloso, Nayaret"

Now showing items 1-4 of 4

    • Diversidad de las comunidades microbianas adherentes en biopsias de mucosa colónica de pacientes chilenos ... 
      Chamorro Veloso, Nayaret (Universidad de Chile, 2019)
      La mayor concentración y diversidad de microorganismos asociados a la microbiota humana reside en el intestino, estableciendo una relación comensal o mutualista con el hospedero, la cual puede verse interrumpida cuando la ...
    • Glucocorticoids impair phagocytosis and inflammatory response against crohn's disease-associated adherent-invasive ... 
      Olivares Morales, Mauricio; Fuente, Marjorie de la; Dubois Camacho, Karen; Palominos Parada, Daniela Paz; Díaz Jiménez, David; Torres Riquelme, Alejandro; Xu, Xiaojiang; Chamorro Veloso, Nayaret; Naves, Rodrigo; González Burgos, María Julieta; Quera Pino, Rodrigo; Figueroa, Carolina; Cidlowski, John Anthony; Vidal, Roberto; Hermoso Ramello, Marcela (Frontiers Media, 2018)
      Crohn's disease (CD) is a chronic inflammatory bowel disorder characterized by deregulated inflammation triggered by environmental factors Notably, adherent-invasive Escherichia coli (AIEC), a bacterium with the ability ...
    • New insights for vaccine development against Clostridium difficile infections 
      Pizarro-Guajardo, Marjorie; Chamorro Veloso, Nayaret; Vidal, Roberto Mauricio; Paredes Sabja, Daniel (Academic Press, 2019)
      Increased antibiotic usage is the main risk factor for gut microbiota dysbiosis. In dysbiosis, there is an increased susceptibility to intestinal pathogens, such as Clostridium difficile infection, the leading cause of ...
    • Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis 
      Ogonowski, Natalia; Salcidua, Stefanny; León Albarracín, Tomás; Chamorro Veloso, Nayaret; Valls, Cristian; Avalos, Constanza; Bisquertt, Alejandro; Rentería, Miguel E.; Orellana, Paulina; Duran Aniotz, Claudia (Frontiers Media, 2022)
      The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at > 10% per year, reaching up to 80-90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, ...